Pharmacological interaction of drugs with immune receptors: the p-i concept.
about
Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosingA comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirementsBasophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions-Potential and LimitationsToxic epidermal necrolysisEvolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.Drug hypersensitivity reactions targeting the skin in dogs and catsSulfamethoxazole induces a switch mechanism in T cell receptors containing TCRVβ20-1, altering pHLA recognitionDrug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoireStructural Basis of Chronic Beryllium Disease: Linking Allergic Hypersensitivity and AutoimmunityFever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responsesStudy of protein haptenation by amoxicillin through the use of a biotinylated antibioticThe Possible Mechanism of Idiosyncratic Lapatinib-Induced Liver Injury in Patients Carrying Human Leukocyte Antigen-DRB1*07:01Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cellsAdverse Drug Reactions in Children: The Double-Edged Sword of Therapeutics.Pharmacogenomics of off-target adverse drug reactions.PharmGKB summary: abacavir pathwaySmall molecules as friends and foes of the immune system.Antiviral drug allergy.Pharmacogenetics of drug hypersensitivity.Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxisVgamma2Vdelta2 T Cell Receptor recognition of prenyl pyrophosphates is dependent on all CDRsT cell-mediated hypersensitivity reactions to drugsPharmGKB summary: very important pharmacogene information for human leukocyte antigen B.Association of human leukocyte antigen alleles and nevirapine hypersensitivity in a Malawian HIV-infected population.Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Photoaffinity antigens for human gammadelta T cells.MHC restriction and allogeneic immune responses.Immune mediation of hypersensitivity adverse drug reactions: implications for therapy.In vitro testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review.Effector and regulatory mechanisms in allergic contact dermatitis.The HLA-A*31:01 allele: influence on carbamazepine treatmentIn vitro tests of T cell-mediated drug hypersensitivity.Pharmacogenetics of toxic epidermal necrolysis.γδ T cell receptor ligands and modes of antigen recognitionHLA alleles and drug hypersensitivity reactions.T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction.Pharmacogenomics of adverse drug reactions: implementing personalized medicine.The structural basis of HLA-associated drug hypersensitivity syndromes.Studies on abacavir-induced hypersensitivity reaction: a successful example of translation of pharmacogenetics to personalized medicine.
P2860
Q24626941-5315E9C3-B97F-4CA1-A898-4CEE05879BAAQ26744352-C2A6B48C-FE36-4686-BAFE-3125A5B4B289Q26744628-1462152F-8057-4740-B404-F2981A98EB84Q26745232-C28A8EE0-FDC1-4987-B820-F7BC5F5CC84AQ26800980-7DCE08E4-53C3-4A6D-B354-5B0536FF3980Q26822023-875A01DB-E468-49FE-AB91-31416ADD5D66Q27304795-B1538A07-FEEC-4C25-A194-03D9DE1457F8Q27679355-2557CF04-A3A3-4ABB-922A-DE606AE8909BQ27684560-931BC022-2C43-4EC0-AE0D-7AB0C2F9592CQ27692095-3ED0045A-A13E-45CA-9E8B-AA897179FFA5Q28538078-40E50185-DF44-43C5-80B9-1BA071F54492Q28540335-967449A4-408F-4106-8A36-90DA0350B017Q28548544-88F0AA16-B27A-4AC7-B0FE-FA3DEB23539EQ28660812-BF311A70-AEF3-43CA-80FD-DF45FE8C906CQ30235268-5C0D174B-ECA3-48A3-8C45-473FE4DBCBBAQ30400366-4DD0BDBA-44F9-4BB0-B939-4BC7C75BACC6Q33819062-B601B1C4-C874-4F28-9260-3BB6B98D90B5Q33852354-98A142BF-F201-4760-A04A-7192F1FAD5BBQ34075812-67D500B4-EA96-452B-86F0-496DDC3FEE22Q34118186-6701FECD-D66E-4642-AE4E-F01948FBADBBQ34209489-FFE8C3A6-1329-4FFC-8D7E-A02E87987658Q34749889-20DE22DA-960B-48A2-88C7-2F686C3E6C1FQ34971993-78AC30CA-3CBF-4826-918A-D83E409F7CB1Q35168561-B195936C-BE4B-46CE-942E-86A38D73E8C9Q36740238-61106889-9E03-4044-B654-AA4657711ED1Q37121662-B8FEE83E-A3A3-4D16-B2F6-664F8D70D528Q37226687-63813DF2-C27E-44AD-85BD-D5DD37AA37EFQ37464963-74F7F361-55A4-4ED3-9760-1B5AECF23C8AQ37510953-5D4AFE2B-EB8F-47BE-BEFF-04F52156836FQ37605792-632F142F-5315-4E19-8B77-66628B29538BQ37617470-F6AEEA8C-8FD9-414C-8F8C-CF68AD8257F0Q37626751-0BA0161E-B242-4BB9-A23D-E2B071A8C083Q37754599-0D961F68-84C8-4913-B606-C8D9762D2BC8Q37763930-CB681F79-13BF-432E-BFE3-8C79CA61ACB0Q37836561-3037A313-A3DE-468A-B5AD-E5A70A1E8DE4Q37963995-AB9DAA99-4C18-4DCD-BCD1-5689C37F0465Q38033651-750A8DB5-059A-4A30-B0B6-1987B894E392Q38036150-2A92FE47-8E60-4638-9E12-74344F38A49CQ38050483-AA1C4588-799F-4C05-AF89-FE97D1440F4CQ38080040-FAA317F6-6DA6-41FF-9A83-C0A689849CAB
P2860
Pharmacological interaction of drugs with immune receptors: the p-i concept.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pharmacological interaction of drugs with immune receptors: the p-i concept.
@ast
Pharmacological interaction of drugs with immune receptors: the p-i concept.
@en
type
label
Pharmacological interaction of drugs with immune receptors: the p-i concept.
@ast
Pharmacological interaction of drugs with immune receptors: the p-i concept.
@en
prefLabel
Pharmacological interaction of drugs with immune receptors: the p-i concept.
@ast
Pharmacological interaction of drugs with immune receptors: the p-i concept.
@en
P2093
P1476
Pharmacological interaction of drugs with immune receptors: the p-i concept
@en
P2093
Andreas Beeler
Anna Zawodniak
Basil Gerber
Daphné Schmid
Monika Keller
Sinforiano Posadas
Zoi Spanou
P356
10.2332/ALLERGOLINT.55.17
P577
2006-03-01T00:00:00Z